A new trading day began on Friday, with Guardant Health Inc (NASDAQ: GH) stock price up 0.25% from the previous day of trading, before settling in for the closing price of $94.13. GH’s price has ranged from $28.45 to $101.57 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -33.61% over the past five years. Meanwhile, its annual earnings per share averaged 13.27%. With a float of $123.69 million, this company’s outstanding shares have now reached $125.01 million.
Guardant Health Inc (GH) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Guardant Health Inc is 4.39%, while institutional ownership is 95.27%. The most recent insider transaction that took place on Nov 07 ’25, was worth 142,780. In this transaction Director of this company sold 1,500 shares at a rate of $95.19, taking the stock ownership to the 815 shares. Before that another transaction happened on Nov 07 ’25, when Company’s Chief Legal Officer sold 8,996 for $96.25, making the entire transaction worth $865,865. This insider now owns 43,172 shares in total.
Guardant Health Inc (GH) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.62 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.27% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.42% during the next five years compared to -33.61% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Here are Guardant Health Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.21, a number that is poised to hit -0.78 in the next quarter and is forecasted to reach -2.76 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Guardant Health Inc (NASDAQ: GH) saw its 5-day average volume 2.19 million, a negative change from its year-to-date volume of 2.47 million. As of the previous 9 days, the stock’s Stochastic %D was 51.90%.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 88.24%, which indicates a significant increase from 78.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 5.34 in the past 14 days, which was higher than the 2.81 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $70.75, while its 200-day Moving Average is $53.01. Nevertheless, the first resistance level for the watch stands at $96.62 in the near term. At $98.87, the stock is likely to face the second major resistance level. The third major resistance level sits at $101.97. If the price goes on to break the first support level at $91.28, it is likely to go to the next support level at $88.18. Assuming the price breaks the second support level, the third support level stands at $85.93.
Guardant Health Inc (NASDAQ: GH) Key Stats
With a market capitalization of 12.21 billion, the company has a total of 126,041K Shares Outstanding. Currently, annual sales are 739,020 K while annual income is -436,370 K. The company’s previous quarter sales were 265,200 K while its latest quarter income was -92,730 K.
